About
Venus Medtech (Hangzhou) Inc. is a prominent Chinese medical device company based in Hangzhou, Zhejiang. Founded in 2009, it specializes in the design, development, and commercialization of transcatheter heart valve products for structural heart diseases. The company is recognized as a leader in transcatheter aortic valve replacement (TAVR) in China, holding a significant market share. The product portfolio includes a variety of transcatheter heart valve solutions targeting all four heart valves. This includes aortic valve products like Venus-PowerX and Venus-Vitae, a pulmonary valve designed for severe regurgitation, and devices for mitral and tricuspid valve diseases. Venus Medtech also offers platforms such as Liwen RF and Echomplish, which address broader structural heart disease needs. With a strong emphasis on innovation, Venus Medtech holds over 800 patents globally and has received numerous awards for its contributions to the medical device field. The company employs around 835 people and reported revenue of $45.9 million, serving hospitals and healthcare providers focused on cardiovascular interventions.
Technologies
Keywords
Company Information
-
Employees 700
-
Founded 2009
-
Annual Revenue $64503000
-
Total Funding $190000000
Location
Jiang Ling Lu, Hang Zhou Shi, Zhe Jiang Sheng, China
